New York, NY -- (ReleaseWire) -- 01/07/2013 -- Advanced Cell Technology Inc. (OTCQB: ACTC), a biotechnology company focusing on the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology, is rallying in trading today, extending its gains from last week.
ACTC is gaining momentum today after the company announced that it will make a presentation at the Biotech Showcase™ 2013 on January 8, 2013 in San Francisco. At last check, ACTC was trading 19.90% higher at $0.0958 on volume of 37.93 million, which is more than four times the daily average volume of 8.22 million.
ACTC has now gained more than 65% in the last three trading sessions. The stock has broken through some technical levels as a result of the rally. Technical indicators suggest that the upward momentum will continue.
Find out how far this announcement could take ACTC by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=ACTC
Fannie Mae (OTCQB: FNMA), a government-sponsored enterprise (GSE) chartered by the U.S. Congress to support liquidity and stability in the secondary mortgage market, has risen sharply in trading today after Bank of America Corp. (NYSE: BAC) said that it will pay $3.6 billion to FNMA and will buy back $6.75 billion in loans it sold the government agency from January 1, 2000 through December 31, 2008.
The agreements settle mortgage claims resulting from the housing market crash 2008.
At last check, FNMA was trading 7.98% higher at $0.284 on volume of 9.19 million, which is nearly four times the daily average volume of 2.43 million. FNMA has broken through $0.28 resistance level as a result of the rally today. The next resistance level for the stock will be at $0.30.
Find out what more is to know about FNMA by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=FNMA
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
WALL STREET REPORT